Submitted to the Public Health Agency of Canada
Contract Number: CW2340342
Prepared By: Leger
Ce rapport est également disponible en français.
Contract value: $300,000.00
Award date: December 5, 2023
Delivery date: March 28, 2024
Registration number: POR 099-23
For more information on this report, please contact cpab_por-rop_dgcap@hc-sc.gc.ca
Leger
507 Place d'Armes, Suite 700
Montréal, Quebec
H2Y 2W8
Telephone: 514-982-2464
Fax.: 514-987-1960
Final Report
Prepared for the Public Health Agency of Canada
Supplier Name: Leger Marketing Inc.
March 2024
This public opinion research report presents the methodology of a telephone survey conducted by Leger Marketing Inc. on behalf of the Public Health Agency of Canada. The research was conducted with 5,364 Canadians between January 3 and March 5, 2024.
Cette publication est aussi disponible en français sous le titre : Enquête sur la couverture vaccinale contre la grippe saisonnière, 2023-2024.
This publication may be reproduced for non-commercial purposes only. Prior written permission must be obtained from Health Canada. For more information on this report, please contact Health Canada at cpab_por-rop_dgcap@hc-sc.gc.ca or at:
Health Canada, CPAB
200 Eglantine Driveway, Tunney's Pasture
Jeanne Mance Building, AL 1915C
Ottawa, Ontario K1A 0K9
Catalogue Number: HP5-244/2024E-PDF
International Standard Book Number (ISBN): 978-0-660-71725-8
Related publications (registration number: POR 099-23):
Catalogue Number: HP5-244/2024F-PDF (Final Report, French)
©His Majesty the King in Right of Canada, as represented by the Minister of Health, 2024.
Leger is pleased to submit this methodological report to the Public Health Agency of Canada (PHAC) of a quantitative survey assessing seasonal influenza vaccination coverage among the Canadian population.
This report was prepared by Leger following the awarding of a contract to PHAC (contract number CW2340342), awarded December 5, 2023. This contract has a value of $300,000.00 (including HST).
Influenza usually occurs in the northern hemisphere between November and April. In Canada, an average of 12,200 hospitalizations and 3,500 deaths related to influenza occur each year. The risk of hospitalization is greatest in very young children and elderly persons. The best way to prevent influenza is by getting the influenza vaccine.
The National Advisory Committee on Immunization (NACI) recommends that every year, individuals six months and older receive an influenza vaccine. This is especially true for populations at high risk for influenza-related complications such as those with chronic medical conditions (CMCs), older adults (aged 65 years and older), and young children (aged six to 59 months). Canadian provinces and territories launch their influenza vaccination programs before influenza begins spreading in the community, usually beginning in October and continuing on past December. Vaccination continues to be offered throughout the influenza season, as long as influenza viruses are circulating.
There are two main types of influenza viruses that cause outbreaks and epidemics: influenza A and B. Influenza A and B viruses are further broken down into subtypes and lineages, respectively. Across influenza seasons, different subtypes and/or lineages are in circulation, so experts must create a new influenza vaccine each year. Further, the effectiveness of the vaccine can wear off over time. This is why it is important to get a new influenza vaccine every year. Monitoring influenza vaccine coverage across the country helps PHAC assess how well the general population in Canada are protected from the virus.
Slightly higher than the World Health Organization (WHO) coverage goals of 75%, the Canadian national influenza vaccination coverage goals for seniors aged 65 and older and adults aged 18–64 years with CMCs were set at 80% in 2017 to be reached by 2025. Measuring vaccine coverage against the national goals on a routine basis plays an important role in protecting the health of Canadians for a number of reasons. First, it allows for the monitoring and evaluation of vaccination programs across years, and across different seasons for influenza. Second, it identifies factors influencing influenza vaccine uptake and sub-populations with low vaccine coverage, to support developing targeted programs for improving vaccine coverage in un- and under-vaccinated populations. Finally, it allows for the fulfillment of various reporting activities, such as performance measurement indicators, monitoring progress towards national vaccination coverage goals, and obligations to international health partners such as the Pan American Health Organization.
This year, with the ongoing circulation of SARS-CoV-2, an emerging threat of concurrent influenza and COVID-19 epidemics is a major concern for public health officials and clinicians. In order to survey people on their attitudes and beliefs toward COVID-19 vaccines, as well as their intent or acceptance of co-administration of the COVID-19 and flu vaccine, the section of COVID-19 vaccine-related questions introduced last year will again be used in the Seasonal Influenza Vaccination Coverage Survey 2023-2024 questionnaire.
In light of the first vaccine for respiratory syncytial virus (RSV) for adults aged 60 and over being approved by Health Canada recently, we have incorporated new questions to gain a better understanding of people's knowledge about the RSV vaccine and their intent to get vaccinated when it becomes accessible. These questions aim to assess awareness regarding this important preventive measure and to gather valuable insights into the public's potential adoption of this vaccination.
The primary objective of the research is to provide national vaccination coverage estimates for the seasonal influenza vaccine. Specifically, the survey will be used to:
The results of this study will help the Public Health Agency of Canada (PHAC) to identify at-risk populations with lower immunization coverage, recognize factors leading to vaccine uptake or refusal, measure the performance of vaccination programs, and design future vaccination programs in Canada. The survey results also allow PHAC to monitor and evaluate vaccination programs during the flu seasons.
The quantitative research consisted of telephone interviews, which were conducted using a computer-assisted telephone interviewing system (CATI technology).
Data collection for this survey took place between January 3 to March 5, 2024. The national response rate for the survey was 10.39 %. The comprehensive distribution of calls is presented in Appendix A. A pre-test of 58 interviews, in both official languages, was conducted between January 3 and 4, 2024. More specifically, 32 interviews were conducted in French and 26 in English. Aside from a minor programming error that has been corrected, no changes were made to the questionnaire or the programming following the pre-test. A second pre-test was conducted to ensure correct programming, and data collection began as planned. Aside from responses that were affected by the programming error, all pre-test responses were included in the overall results. The interviews lasted an average of twenty-one minutes The interviews were recorded to assess the level of understanding of each question among respondents.
To obtain reliable data for each of the subgroups, we surveyed a total sample of 5,364 Canadian adults in all regions of the country. Only one adult respondent was interviewed per household. The national margin of error for this survey is +/- 1.3%, 19 times out of 20.
The main target population in this study was Canadian adults aged 18 and older who were making vaccine-related decisions for themselves. As was the case in previous years, the final analysis of the study focused on 3 different target groups:
A proportion of the interviews was conducted with a sample of cell-phone numbers (cell-phone-only household members), in order to provide an adequate and reliable sample of the youth cohort (18 to 34). While the cell-phone sample did not exclusively target the youth cohort, this age group was over-indexed in that target sample. The other interviews were conducted with landline users. According to 2021 national census data from Statistics Canada, Leger weighted the results of this survey by age, gender, region, language (mother tongue) and education level. Results were also weighted by households with a landline phone and household with cellphones only, according to the latest Canadian Radio-Television and Telecommunications commission (CRTC) data available.
Leger meets the strictest quantitative research guidelines. The questionnaire was prepared in accordance with the Standards for the Conduct of Government of Canada Public Opinion Research—Series B—Fieldwork and Data Tabulation for Telephone Surveys. Details on the methodology, Leger's quality control mechanisms, the questionnaire, and the weighting procedures are provided in the appendix.
The opinions and observations expressed in this document do not reflect those of the Public Health Agency of Canada. This report was compiled by Leger based on research conducted specifically for this project. This research is probabilistic; the results can be applied to the general population of Canada. The research was designed with this objective in mind.
I hereby certify, as chief agent of Leger, that the deliverables are in full compliance with the neutrality requirements of the Policy on Communications and Federal Identity and the Directive on the Management of Communications—Appendix C (Appendix C: Mandatory Procedures for Public Opinion Research).
Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, party positions, or the assessment of the performance of a political party or its leaders.
Signed by:
Christian Bourque
Executive Vice President and Associate
Leger
507 Place d'Armes, Suite 700
Montréal, Quebec
H2Y 2W8
cbourque@leger360.com
For tracking and comparability purposes, the methodology used for this survey was the same as that of previous waves of surveys. Leger used the same methods as those used in the 2022-2023 survey with respect to sampling methodology, data collection methods and some elements of the questionnaire.
The quantitative research consisted of telephone interviews, which were conducted using a computer-assisted telephone interviewing system (CATI technology). This approach is the most suitable for assessing seasonal influenza vaccination coverage among different subgroups of the Canadian population, while ensuring a high level of representativeness.
Leger meets the strictest quantitative research guidelines. The survey questionnaire was prepared in accordance with the Standards for the Conduct of Government of Canada Public Opinion Research—Series B—Fieldwork and Data Tabulation for Telephone Surveys.
Respondents were assured of the voluntary and confidential nature of the approach, and the anonymity of their responses. As with all research conducted by Leger, any information that could identify respondents was removed from the data, in accordance with Canada's Privacy Act.
Research interviews were conducted from the Montréal and Winnipeg virtual call centres. The Montreal call centre has three separate divisions of interviewers: one made up exclusively of English-speaking interviewers, another exclusively of French-speaking interviewers, and the last of bilingual interviewers. These divisions ensure that all telephone surveys can easily be conducted in either official language. Interviews in English were also conducted from the Winnipeg call centre.
Data collection for this survey was conducted between January 3 and March 5, 2024. The national response rate for the survey was 10.39 %. The comprehensive distribution of calls is presented below. A pre-test of 58 interviews, in both official languages, was conducted between January 5 and 6, 2024. More specifically, 32 interviews were conducted in French and 26 in English. The interviews lasted an average of twenty-one minutes.
To obtain reliable data for each of the subgroups, we surveyed a total sample of 5,364 Canadian adults who had access to either a landline or a cellphone in all regions of the country. Only one adult respondent was interviewed per household. Canadians without a landline or cellphone were excluded from the study. This research is probabilistic; the results can be applied to the general population of Canada. The national margin of error for this survey is +/- 1.3%, 19 times out of 20.
Representative sample of approximately 5,210 Canadians
A sample of Canadian adults was selected randomly using a stratified regional sampling approach. Flexible regional quotas were applied to ensure that a sufficient number of interviews were conducted in each region of Canada.
The following table details the regional quotas for the 5,210 Canadian adults and the effective distribution of the 5,364 respondents:
| Region | Quotas | Number of completed interviews |
|---|---|---|
| Newfoundland and Labrador | 300 | 326 |
| Prince-Edward-Island | 300 | 298 |
| Nova-Scotia | 300 | 328 |
| New-Brunswick | 300 | 310 |
| Quebec | 725 | 731 |
| Ontario | 1,235 | 1,413 |
| Manitoba | 350 | 334 |
| Saskatchewan | 400 | 380 |
| Alberta | 500 | 515 |
| British Columbia | 500 | 529 |
| Nunavut* | 100 | 32 |
| Northwest Territories* | 100 | 82 |
| Yukon* | 100 | 86 |
| Total | 5,210 | 5,364 |
| * Due to the difficulty of reaching respondents in the territories, the quota of 100 respondents was flexible. The missing sample was spread out between the rest of provinces and territories. | ||
Landline telephone numbers were generated, and only cell phone numbers were purchased1 using a stratified regional sampling approach. Telephone interviews were conducted using Leger's computer-assisted telephone interviewing system (CATI technology). This system manages the sampling electronically, by selecting and randomly dialing the phone number to call. To ensure perfect coverage of a population, the sample included residential telephone numbers located in all of Canada's provinces and territories, as well as the cell phone numbers of Canadians who do not have a residential landline (i.e., pre-validated cell numbers only). Flexible quotas were established to ensure a sufficient number of interviews in each region of Canada. In addition to these regional quotas, data was collected to ensure proper distribution of respondents by gender (men and women) and language (English and French), using flexible quotas.
Canada-wide sampling: Households with a landline
We defined a Canada-wide sample of telephone numbers. All numbers were randomly selected to generate this basic sample. Each telephone number in this sampling frame was associated with a Canadian province. Subsequently, we used this Canada-wide sample to randomly select numbers by province or region, in proportion with the provincial or regional quotas established for the project.
Canada-wide sampling: households with a cell phone number only
For the portion of the sample composed of "cell phone only households," candidates were randomly selected for each province or region taking into account provincial or regional quotas. The precise target of 2,500 respondents from cellphone only households was set and reached to match as closely as possible the proportion of Canadian cellphone only households estimated by the CRTC (48%). Only after the data collection, it was found that the proportion of Canadian cellphone only households is now estimated to be at 52.2%. Statistical weighting corrected that change, as well as the demographic differences between the sample and the actual proportion in the population.
A low response rate compromises the reliability and validity of a survey. Based on their experience in surveying various populations, Leger has established the following methods to maximize response rates:
The overall response rate for this study was 10.39%. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
| Base Sample | 122,671 |
|---|---|
| Invalid number | 49,317 |
| No service | 48,434 |
| Non-residential | 231 |
| Fax / modem / pager | 632 |
| Double | 20 |
| Unresolved (U) | 54,580 |
| No answer | 18,175 |
| Answering machine | 35,409 |
| Line busy | 996 |
| EFFECTIVE SAMPLE* | 24,138 |
| In-scope non-responding units (IS) | 11,154 |
| Refusal | 10,536 |
| Language Barrier | 618 |
| Responding units (R) | 7,620 |
| Quota attained | 18 |
| Unqualified | 679 |
| Incomplete | 320 |
| Appointment | 1,239 |
| COMPLETED INTERVIEWS | 5,364 |
| Participation rate | 10.39% |
An effective response rate of 10 % is around the average for a national telephone survey of 5,364 respondents conducted over a period of approximately five weeks. This rate is consistent with similar surveys. Based on Leger's experience, a response rate of more than 10% is considered typical and within industry standards for a telephone survey with the general population.
Weighting
According to Statistics Canada's 2021 national census data, Leger weighted the results of this survey by age, gender, region, language (mother tongue) and education level. In addition, the weighting of respondents in the cell phone-only sample was also controlled to match the 52.2% of Canadian households with cellphones only and to correct the difference between the sample and the actual proportion in the population, as per our new estimate of Statistic Canada's data.
A baseline comparison of weighted and unweighted samples was also conducted to identify potential non-response biases that could be introduced by lower response rates in some demographic subgroups (see tables in the next section). As is usually the case for a telephone survey targeting mainly households with a landline, it was more difficult to reach young respondents. To compensate for this, Leger conducted 2,500 interviews with individuals whose homes do not have landlines (called on their cell phones) in order to maximize the number of youth in the final sample.
The table below shows the geographical distribution of respondents, before and after weighting. Given the bigger sample size, and the desire to have more robust sample size in each Canadian region, bigger quotas were set in smaller regions, resulting in a more substantial geographical distribution imbalance in the unweighted sample. The weighting process mainly adjusted the weights of Manitoba, Saskatchewan and the Atlantic provinces, which was overrepresented in the sample, and of British Columbia, Quebec and Ontario, which were underrepresented. Nunavut, Northwest Territories and Yukon, which were slightly overrepresented in the sample.
| Province or territory | Unweighted | Weighted |
|---|---|---|
| Newfoundland and Labrador | 335 | 90 |
| Prince Edward Island | 300 | 33 |
| Nova Scotia | 303 | 143 |
| New Brunswick | 300 | 124 |
| Quebec | 725 | 1,210 |
| Ontario | 1,416 | 2,022 |
| Manitoba | 350 | 215 |
| Saskatchewan | 400 | 195 |
| Alberta | 500 | 562 |
| British Columbia | 505 | 718 |
| Nunavut | 30 | 4 |
| Northwest Territories | 100 | 20 |
| Yukon | 100 | 27 |
The tables below illustrate the demographic distribution of respondents by gender, age, language (mother tongue), and education level.
First, with respect to gender, we can see that the weighting adjusted the proportion of female respondents to male respondents, with women still a little over-represented in telephone surveys.
| GENDER | Unweighted | Weighted |
|---|---|---|
| Male | 2,365 | 2,546 |
| Female | 2,953 | 2,748 |
| Other | 24 | 37 |
| Don't know | 7 | 11 |
| Refusal | 15 | 22 |
With respect to age distribution, the final weighting of the results corrected some imbalances regarding age groups. Respondents under 55 years old were underrepresented in the final sample, and respondents aged 55 years and older were overrepresented. The weighting corrected that discrepancy.
| AGE | Unweighted | Weighted |
|---|---|---|
| From 18 to 24 years old | 246 | 541 |
| From 25 to 34 years old | 482 | 889 |
| From 35 to 44 years old | 719 | 884 |
| From 45 to 54 years old | 777 | 842 |
| From 55 to 64 years old | 1,062 | 941 |
| From 65 to 74 years old | 1,252 | 730 |
| 75 years and older | 826 | 536 |
Some imbalances in language distribution were corrected through weighting, as shown below. The French-speaking respondents were slightly underrepresented and, as such, the weighting corrected that discrepancy.
| LANGUAGE (MOTHER TONGUE) | Unweighted | Weighted |
|---|---|---|
| French | 911 | 1,055 |
| English | 3,732 | 3,342 |
| Other | 712 | 956 |
| Don't know | 3 | 1 |
| Refusal | 6 | 9 |
Regarding education level, weighting adjusted the weights of respondents who have a college and less education level who were underrepresented in the sample, while those with a university degree were overrepresented.
| EDUCATION LEVEL | Unweighted | Weighted |
|---|---|---|
| High school or less | 1,448 | 1,757 |
| College | 1,418 | 1,885 |
| University | 2,433 | 1,655 |
The following table details the demographic distribution of respondents based on their phone equipment: whether they only had a cellphone or not. With the proportion of cellphone only households jumping to 52.2%, Those who only had a cellphone were slightly underrepresented in the sample.
| PHONE EQUIPMENT | Unweighted | Weighted |
|---|---|---|
| Cellphone only | 2,500 | 2,800 |
| Not cellphone only | 2,845 | 2,548 |
The weighting applied corrected the original imbalance for data analysis purposes; no further manipulation was required.
As with all research conducted by Leger, contact information was kept completely confidential, and any information that could identify respondents was removed from the data, in accordance with Canada's Privacy Act.
Certain subgroups tend to be underrepresented or overrepresented in a sample compared to the general population. The weighting of a sample makes it possible to correct for differences in the representation of the various subgroups of that sample compared to what is usually observed in the overall study population. Weighting factors are therefore the weight given to each respondent that corresponds to a subgroup of the sample.
The following tables illustrate the proportion allocated to each target in the sample.
| GENDER*AGE | Proportion (%) |
|---|---|
| Male AND aged 18 to 24 years | 5.215 |
| Male AND aged 25 to 34 years | 8.326 |
| Male AND aged 35 to 44 years | 8.105 |
| Male AND aged 45 to 54 years | 7.693 |
| Male AND aged 55 to 64 years | 8.578 |
| Male AND aged 65 and older | 10.842 |
| Female AND aged 18 to 24 years | 4.880 |
| Female AND aged 25 to 34 years | 8.253 |
| Female AND aged 35 to 44 years | 8.381 |
| Female AND aged 45 to 54 years | 7.999 |
| Female AND aged 55 to 64 years | 8.957 |
| Female AND aged 65 and older | 12.771 |
| Total | 100% |
| GENDER*REGION | Proportion (%) |
|---|---|
| Newfoundland AND Male | 0.696 |
| Newfoundland AND Female | 0.739 |
| Prince Edward Island AND Male | 0.204 |
| Prince Edward Island AND Female | 0.218 |
| Nova Scotia AND Male | 1.299 |
| Nova Scotia AND Female | 1.402 |
| New Brunswick AND Male | 1.050 |
| New Brunswick AND Female | 1.104 |
| Quebec AND Male | 11.273 |
| Quebec AND Female | 11.741 |
| Ontario AND Male | 18.704 |
| Ontario AND Female | 19.905 |
| Manitoba AND Male | 1.718 |
| Manitoba AND Female | 1.777 |
| Saskatchewan AND Male | 1.434 |
| Saskatchewan AND Female | 1.479 |
| Alberta AND Male | 5.486 |
| Alberta AND Female | 5.600 |
| British Columbia AND Male | 6.752 |
| British Columbia AND Female | 7.130 |
| Yukon Territory AND Male | 0.053 |
| Yukon Territory AND Female | 0.055 |
| Northwest Territories AND Male | 0.053 |
| Northwest Territories AND Female | 0.052 |
| Nunavut AND Male | 0.039 |
| Nunavut AND Female | 0.038 |
| Total | 100% |
| REGION*LANGUAGE | Proportion (%) |
|---|---|
| Quebec AND French | 17.223 |
| Quebec AND English | 5.791 |
| Rest of Canada AND French | 2.450 |
| Rest of Canada AND English | 74.536 |
| Total | 100% |
| HOUSEHOLDS WITH A CELL PHONE NUMBER ONLY | Proportion (%) |
|---|---|
| Yes | 52.200 |
| No | 47.800 |
| Total | 100% |
| HIGHEST EDUCATION LEVEL COMPLETED | Proportion (%) |
|---|---|
| No University | 69.152 |
| University | 30.848 |
| Total | 100% |
Seasonal Influenza Vaccination Coverage Survey, 2023-2024
X= Exclusive choice
F= Fixed Choice (not part of the rotation or permutation)
O= Open-ended
[ASK ALL]
QINF#
Hello / Bonjour (pause), the Government of Canada is conducting a research survey on the influenza vaccine, also known as the flu shot. Would you prefer that I continue in English or French? Préférez-vous continuer en français ou en anglais?
[Continue survey in language of choice of respondent. If interview is unable to continue in French, say: "Je vous remercie. Quelqu'un vous rappellera bientôt pour mener le sondage en français. »]
My name is [first name] of Leger, the company hired to do the survey. The survey takes about 15 minutes to complete. Should you have any questions about the survey, I can give you a contact person within the Government of Canada. Your participation is voluntary and confidential. Your answers will remain anonymous, and the information you provide will be administered according to the requirements of the Privacy Act, the Access to Information Act, and any other pertinent legislation. Is this a safe and convenient time for you? May I continue?
We are currently conducting a study on the influenza vaccine, as known as the flu shot. This survey is led by the Public Health Agency of Canada. Your answers will help improve services that impact Canadians like you. We would therefore greatly appreciate your cooperation.
IF ASKED: Your opinion counts. Leger is a renowned company throughout Canada. Today's study is about a topic related to public health in Canada. There are no wrong answers. When may I contact you again? When would be a good time to contact you? Whom should I ask to speak with when I call back? Is there another person in your household with whom we could talk?
NOTE: If a respondent requests to speak with a study leader at the Public Health Agency of Canada, please provide the following contact email address.
Contact: coverage-couvertures@phac-aspc.gc.ca.
Note to the interviewer: If a respondent asks you about the legitimacy of this project or if the respondent wants to make a complaint or a comment about this project, you must invite him/her to visit the CRIC Website: https://www.canadianresearchinsightscouncil.ca/ (English) or https://www.canadianresearchinsightscouncil.ca/?lang=fr (French), and you must give him the CRIC Project Registration Number: 20231213-LE351
[ASK ALL]
INTERVIEWER SCRIPT:
To begin, I have a few questions about you.
[ASK IF ECHA=CELL]
Do you currently have a residential land-line telephone service at home?
INTERVIEWER INSTRUCTIONS: (DO NOT READ LIST. ONLY ONE MENTION)
Yes 1 RECODE LANDLINE
No 0
(DO NOT READ) Valid skip / Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9 TERMINATE
[ASK ALL]
[NUMeric : Min=18, Max=150]
[NOTES: Under 18 = terminate]
[VALIDATION: AGE]
How old were you as of September 1, 2023?
INTERVIEWER INSTRUCTIONS: (RECORD THE NUMBER.)
Enter number XXX
(DO NOT READ) Refusal 999 TERMINATE
Calculated variable
[NOTES: CALCULATION FROM ADTDEM_010]
Under 18 0 TERMINATE
...Between 18 and 24 1
...Between 25 and 34 2
...Between 35 and 44 3
...Between 45 and 54 4
...Between 55 and 64 5
...Between 65 and 74 6
...75 or older 7
Refusal 9 TERMINATE
[ASK ALL]
What is the language you first learned at home in your childhood and that you still understand?
INTERVIEWER INSTRUCTIONS: (DO NOT READ LIST. ONLY ONE MENTION)
French 1
English 2
Other; specify 6
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
What is your gender?
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: Gender is the way a person internally feels and/or publicly expresses in their daily life. A person's gender may differ from the sex they were assigned at birth (male or female). (DO NOT READ LIST. ONLY ONE MENTION)
Man 1
Woman 2
Other; specify 6
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
As far as you know, are you up to date on your vaccines (other than flu and COVID-19 vaccines)?
INTERVIEWER INSTRUCTIONS: DELETED
If asked: COVID-19 vaccination should not be included in being up to date on your vaccines. READ. ONLY ONE MENTION
Yes 1
No 0
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
INTERVIEWER SCRIPT:
The next few questions will ask you how much you agree or disagree with a series of statements. The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree.
[ASK ALL]
"In general, I consider vaccines to be important for my health." :
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"I know enough about vaccines to make an informed decision about getting vaccinated." :
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
INTERVIEWER SCRIPT: Now, I will ask you some questions about the flu vaccine, and your vaccination status.
[ASK ALL]
Before September 1st, 2023, have you ever received the seasonal flu vaccine (also known as the flu shot)?
INTERVIEWER INSTRUCTIONS:
Note: The flu vaccine can be received by a shot (needle) or nasal spray.
(DO NOT READ LIST. ONLY ONE MENTION)
Yes 1
No 0
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
From September 1st, 2023, to now, have you received the seasonal flu vaccine (also known as the flu shot)?
INTERVIEWER INSTRUCTIONS:
(DO NOT READ LIST. ONLY ONE MENTION)
Yes 1
No 0
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTFLU_020=0]
How likely is it that you will get the seasonal flu vaccine between now and June 2024? Would you say you:
INTERVIEWER INSTRUCTIONS: (READ LIST. ONLY ONE MENTION)
Will definitely get one 1
Will probably get one 2
Will probably not get one 3
Will definitely not get one 4
(DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTFLU_020=0]
What was the most important reason why you did not receive the flu vaccine this time? Would you say it is because…?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
If the respondent says, "Other specify" (96) – capture verbatim response. Do not back-code. (READ LIST. ONLY ONE MENTION)
The flu vaccine does not work 01
I did not need the flu vaccine 02
I did not get around to it (e.g. too busy, lack of time) 04
I have concerns about the safety of the flu vaccine, and/or its side effects 03
I wanted to but was not able to get an appointment (e.g. the appointment got cancelled, vaccine was not available when I called) 07
Because of my health condition (e.g. allergic reactions, sickness such as flu or COVID-19 infections) 08
I heard or read negative media (e.g., on social media, blogs, forums) about vaccines
Other reason; specify: 96
(DO NOT READ) Valid skip/ Not applicable 97
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
[ASK IF ADTFLU_040=2]
What was the most important reason why you did not need the flu vaccine this time? Would you say it is because…?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
If the respondent says, "Other specify" (96) – capture verbatim response. Do not back-code. (READ LIST. ONLY ONE MENTION)
I am healthy, and/ or never get the flu 01
Getting the flu doesn't make me that sick 02
I believe in my immune system capacity 03
Protective behaviors are enough to protect me from the flu (e.g. handwashing, mask wearing, avoiding crowds, or physical distancing) 04
I am not exposed to the flu very often (e.g. teleworking, reduced contacts) 05
Other reason; specify: 96
(DO NOT READ) Valid skip/ Not applicable 97
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
[ASK IF ADTFLU_020=1]
In which month did you receive the flu vaccine this time?
INTERVIEWER INSTRUCTIONS: READ. ONLY ONE MENTION
September 2023 0
October 2023 1
November 2023 2
December 2023 3
January 2024 4
February 2024 5
(DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTFLU_020=1]
Where did you receive the flu vaccine this time?
INTERVIEWER INSTRUCTIONS: (READ IF NEEDED - ONE ANSWER ALLOWED)
Vaccination centre 08
Temporary vaccine clinic (i.e. at the mall) 01
Doctor's office / health clinic 02
CLSC / Community health centre or Public health unit 03
Hospital 04
Pharmacy 05
Workplace 06
Retirement residence / eldercare centre 07
Other, specify: 96 FO
(DO NOT READ) Valid skip/ Not applicable 97 F
(DO NOT READ) Don't know 98 F
(DO NOT READ) Refusal 99 F
[ASK if ADTFLU_020=1]
[MENTIONS MULTIPLES : Max=12]
What are the reasons why you decided to receive the flu vaccine this time?
INTERVIEWER INSTRUCTIONS:
If the respondent says "Other specify" (96) – capture verbatim response. Do not back-code. DO NOT READ - MULTIPLE ANSWERS ALLOWED
Please select all that apply.
I want to prevent infection / I do not want to get sick 01
I am at risk because of my health condition 02
I am at risk because of my age 03
I was recommended by a health care professional 04
To prevent the spread of flu in general 05
It is required in my workplace 06
It was offered / free (by employer or other) 08
If not vaccinated, I can transmit the disease to at-risk people (children, elderly or sick people/patients) 09
If not vaccinated, I can transmit the disease to family members, colleagues or friends (without mention of at-risk people) 10
It helps to reduce stress on the healthcare system 13
I receive it every year (no specific reason) 11
Other reasons; specify: 96 O
(DO NOT READ) Valid skip/ Not applicable 97 X
(DO NOT READ) Don't know 98 X
(DO NOT READ) Refusal 99 X
[ASK if ADTFLU_020=1]
Did you encounter any of the following difficulties in scheduling an appointment for getting the flu shot this time?
MULTIPLE ANSWERS ALLOWED
Please select all that apply.
Limited appointment availability (e.g. no flu shot available, difficult to book an appointment) 01
The vaccine was not offered at my usual/convenient/close location 05
I could not receive it at the same time or location as my COVID-19 vaccination 07
03
Lack of walk-in options 04
Language barriers (e.g. information not in my preferred language) 05
Difficulty in booking time off work or school for a vaccine appointment 06
Difficulty in navigating online appointment platform 07
I didn't encounter any difficulties in scheduling an appointment 08
Other, specify 96
(DO NOT READ) Valid skip/ Not applicable 97
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
[ASK ALL]
How likely are you to get the flu vaccine next year (after September 2024)?
Definitely will 01
Probably will 02
Probably will not 03
Definitely will not 04
DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
INTERVIEWER SCRIPT: The next few questions will ask you how much you agree or disagree with a series of statements. The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree.
[ASK ALL]
"The flu vaccine is ineffective to protect you against getting the flu.":
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"Sometimes, you can get the flu from the flu vaccine.":
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: « The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"It's better to get natural immunity (protection) from getting sick with the flu rather than getting vaccinated."
Strongly disagree 01
Somewhat disagree 02
Somewhat agree 03
Strongly agree 04
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"The opinion of my family doctor, general practitioner, nurse practitioner or pharmacist is an important part of my decision when it comes to getting the flu vaccine.":
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"The flu vaccine is safe.":
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"I understand why the flu vaccine is recommended annually." :
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"It is safe to get the flu vaccine and a COVID-19 vaccine at the same time." :
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
"The flu vaccine or a COVID-19 vaccine could be less effective if getting them at the same time." :
INTERVIEWER INSTRUCTIONS:
Clarification, if asked: "The options are: strongly disagree, somewhat disagree, somewhat agree, or strongly agree".
DO NOT READ, UNLESS ASKED BY RESPONDENT.
ONLY ONE MENTION.
Strongly disagree 1
Somewhat disagree 2
Somewhat agree 3
Strongly agree 4
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
HEALTH STATUS
INTERVIEWER SCRIPT:
In this next section, I will ask you a few general questions about your health.
[ASK ALL]
On a scale of one to five, with one being poor and five being excellent, how would you rate your health?
INTERVIEWER INSTRUCTIONS: READ. ONLY ONE MENTION
One (poor) 1
Two (fair) 2
Three (good) 3
Four (very good) 4
Five (excellent) 5
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
[MENTIONS MULTIPLES: Max=12]
[LIST ORDER : IN ORDER]
Are you currently suffering from or being treated for any of the following conditions? Indicate only conditions that have been diagnosed.
INTERVIEWER INSTRUCTIONS: (READ LIST - MULTIPLE ANSWERS ALLOWED)
Please select all that apply.
Asthma 01
Chronic lung disease (such as cystic fibrosis and chronic obstructive pulmonary disease (COPD) 02
A heart condition (such as angina, high blood pressure, heart disease, heart failure and coronary artery disease) 03
Cancer and other immune compromising conditions (due to underlying disease, therapy, or both, such as solid organ transplant or hematopoietic stem cell transplant recipients) 04
Diabetes or other metabolic disorders (such as inherited metabolic disorders and mitochondrial disorders) 05
Chronic liver disease 06
Renal disease including people undergoing chronic dialysis 07
Neurological and neurodevelopmental conditions [includes neuromuscular, neurovascular, neurodegenerative, neurodevelopmental conditions, and seizure disorders, but excludes migraines and psychiatric conditions without neurological conditions] 08
Spleen problems or removal 09
Anemia / hemoglobinopathy 10
Morbid obesity (BMI > 40) 11
Blood disorders (such as sickle cell disease) 12
I am not currently suffering from or being treated for any of these conditions 97
X
(DO NOT READ) Don't know 98 X
(DO NOT READ) Refusal 99 X
[ASK IF ADTDEM_011 = 6, 7 or ADTCMC_010 not in 97, 98, 99]
Did you know that you are considered to be at higher risk of complications from the flu, and it is recommended for you to receive the flu shot every year?
Yes 01
No 00
(DO NOT READ) Valid skip/ Not applicable 97
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
[ASK ALL]
Do you have a regular family doctor, general practitioner, nurse practitioner or pharmacist?
INTERVIEWER INSTRUCTIONS: READ LIST. ONLY ONE MENTION
Yes 1
No 0
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTHLT_020=1]
Since September 1, 2023, have you seen your family doctor, general practitioner, nurse practitioner or pharmacist?
INTERVIEWER INSTRUCTIONS: READ LIST. ONLY ONE MENTION
Yes, I have seen my family doctor, general practitioner, or nurse practitioner 1
Yes, I have seen a pharmacist 2
Yes, I have seen both 3
No 4
(DO NOT READ) Valid skip/ Not applicable 7 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTHLT_030=1 ou 2 ou 3]
Did your family doctor, general practitioner, nurse practitioner or pharmacist recommend that you get the flu vaccine since September 1, 2023?
INTERVIEWER INSTRUCTIONS:
(READ LIST - MULTIPLE ANSWERS ALLOWED)
Yes, my family doctor, general practitioner, or nurse practitioner has recommended it 1
Yes, my pharmacist has recommended it 2
No 3 X
(DO NOT READ) Valid skip/ Not applicable 7 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK ALL]
This flu season, have you had the flu?
INTERVIEWER INSTRUCTIONS:
If asked: "This flu season" means September 1, 2023 to now
If asked: flu refers to influenza, which is different from a stomach flu (i.e. gastrointestinal illness) Symptoms can include sudden onset of high fever, chills, sore throat, cough or muscle pain. READ LIST. ONLY ONE MENTION
Yes, I had the flu 1
I had something, but I'm not sure if it was the flu, or something else 2
No, I did not have the flu 3 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTHLT_050=1]
Would you say that you had a severe, moderate or mild case of the flu?
INTERVIEWER INSTRUCTIONS:
Clarifications, if asked: A mild case might include sudden onset of high fever, chills, sore throat, cough or muscle pain. A moderate case might include sinus or ear infections. A severe case might include hospitalization or pneumonia.
DO NOT READ LIST. ONLY ONE MENTION
Severe case 1
Moderate case 2
Mild case 3
Other, specify 6 X
(DO NOT READ) Valid skip/ Not applicable 7 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTHLT_050=1]
Does having the flu this season affect your likelihood of getting the flu shot next year?
Yes, I am more likely to get the flu shot next year 01
Yes, I am less likely to get the flu shot next year 02
No, it does not affect my likelihood of getting the flu shot next year 00
(DO NOT READ) Valid skip/ Not applicable 7 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK ALL]
Not including this flu season, have you ever had the flu?
INTERVIEWER INSTRUCTIONS:
If asked: "This flu season" means September 1, 2023 to now
If asked: flu refers to influenza, which is different from a stomach flu (i.e. gastrointestinal illness). Symptoms can include sudden onset of high fever, chills, sore throat, cough or muscle pain.
READ LIST. ONLY ONE MENTION
Yes, I have had the flu 1
I had something, but I'm not sure if it was the flu, or something else 2
No, I have never had the flu 3 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTHLT_070=1]
Thinking about the worst flu you ever had, not including this flu season, would you say you had a severe, moderate or mild case of the flu?
INTERVIEWER INSTRUCTIONS:
Clarifications, if asked: A mild case might include sudden onset of high fever, chills, sore throat, cough or muscle pain. A moderate case might include sinus or ear infections. A severe case might include hospitalization or pneumonia.
DO NOT READ LIST. ONLY ONE MENTION
Severe case 1
Moderate case 2
Mild case 3
Other, specify 6 X
(DO NOT READ) Valid skip/ Not applicable 7 X
(DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
INTERVIEWER SCRIPT: Now, I will ask you some questions about the RSV vaccine, and your vaccination intent.
[ASK ALL]
How familiar are you with the respiratory syncytial virus or RSV?
I know the RSV and what symptoms it causes 01
I heard about RSV but do not know what symptoms it causes 02
I have not heard of it 03
DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK ALL]
Respiratory syncytial virus or RSV is a common respiratory virus that usually causes mild cold-like symptoms. Infants and older adults are more likely to develop severe RSV and need hospitalization. If a RSV vaccine was recommended for you and offered free of charge, how likely would you be to receive it?
Definitely would 01
Probably would 02
Probably would not 03
Definitely would not 04
DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTRSV_020 = 03 OR 04]
What is the main reason for not getting a RSV vaccine?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
(READ LIST. ONLY ONE MENTION)
I have concerns about the safety of the RSV vaccine, and/or its side effects 01
I don't know what RSV is 02
I am tired of having to get vaccinated 03
I believe in my immune system capacity 04
Because of my health condition (e.g. allergic reactions, sickness) 05
I am healthy, and/ or never get RSV 06
Protective behaviors are enough to protect me from the RSV (e.g. handwashing, mask wearing, avoiding crowds, or physical distancing) 07
I am not exposed to the virus very often (e.g. teleworking, reduced contacts) 08
I think symptoms of RSV would be minor 09
Other reason; specify: 96
(DO NOT READ) Valid skip/ Not applicable 97 X
DO NOT READ) Don't know 98 X
(DO NOT READ) Refusal 99 X
[ASK ALL]
If offered the option, how likely would you be to receive the flu, COVID-19 and RSV vaccines during the same visit?
Definitely would 01
Probably would 02
Probably would not 03
Definitely would not 04
DO NOT READ) Don't know 8 X
(DO NOT READ) Refusal 9 X
[ASK IF ADTRSV_040 = 03 OR 04]
What is the main reason for not being willing to receive the flu, COVID-19 and RSV vaccines during the same visit? Would you say it is because…?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
(READ LIST. ONLY ONE MENTION)
Receiving three vaccines might cause a higher number of adverse reactions/side effects 01
Vaccines could be less effective than getting them at different time points 02
Three vaccines at the same time can overload my immune system 03
I only want or need one or two of the three vaccines 04
Other reasons; specify 96
DO NOT READ) Valid skip/ Not applicable 97
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
INTERVIEWER SCRIPT: In the context of the COVID-19 pandemic, I will now ask you some questions about COVID-19 vaccination
[ASK ALL]
From September 1st, 2023 to now, have you received a COVID-19 vaccine?
(READ LIST. ONLY ONE MENTION)
Responses:
Yes 01
No, I received one before September 1st, 2023 02
No, I never received a COVID-19 vaccine 03
I already booked an appointment for my COVID-19 vaccine 03
* Don't know 8
* Refusal 9
[ASK IF ADTCOV_010 = 01 or 02]
How likely are you to keep your COVID-19 doses up to date (e.g. continue to receive them as they are recommended by public health)?
(READ LIST. ONLY ONE MENTION)
Responses:
Very unlikely 01
Somewhat unlikely 02
Somewhat likely 03
Very likely 04
* Don't know 8
* Refusal 9
[ASK IF ADTCOV_010 = 01 or 04 or ADTCOV_020 = Very likely(03) or somewhat likely(04)]
What is the main reason why you would receive a COVID-19 vaccine since September 1st, 2023? Would you say it is because…?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
(READ LIST. ONLY ONE MENTION)
To protect myself personally from COVID-19 01
To protect my family members from COVID-19 02
To prevent the spread of COVID-19 in my community 03
To more safely spend time with family and friends in person 05
It is required at my workplace 06
It was recommended by a health care professional 08
For travel related purposes 09
A vaccine targeting new variants is available 10
Other reasons; specify 6
DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTCOV_010 = 02 or 03; ADTCOV_020 = somewhat unlikely or very unlikely]
What is the main reason why you do not intend to get a COVID-19 vaccine since September 1st, 2023? Would you say it is because…?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
(READ LIST. ONLY ONE MENTION)
I have concerns about the safety and/or side effects of having so many COVID-19 vaccines 01
I think COVID-19 vaccines are not effective in protecting me from the virus 02
I am well protected with the doses received previously 03
I am not at high risk of getting COVID-19 04
I already had COVID-19 and believe I am adequately protected by natural immunity 05
Because of my health condition (e.g. allergic reactions, bad reactions to the previous doses) 06
I have concerns getting it with the flu vaccine 07
I don't think COVID-19 infection is serious enough anymore to need a booster dose 08
I heard or read negative media (e.g., on social media, blogs, forums) about vaccines
I did not get around to it (e.g. too busy, lack of time) 10
I wanted to but was not able to get an appointment (e.g. the appointment got cancelled, vaccine was not available when I called) 11
Other reasons; specify 6
DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTFLU_020 = 01 and ADTCOV_010 = 01]
Did you receive the flu and COVID-19 vaccines during the same visit?
Yes 01
No 02
DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTCOV_050 = 01]
What is the main reason why you received the flu and COVID-19 vaccines at the same visit? Would you say it is …?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
(READ LIST. ONLY ONE MENTION)
To save time 01
Easier to book an appointment 02
To help reduce workload for health care system 03
It was recommended by a health care professional 04
The other vaccine was offered during my visit 05
Other reasons; specify 6
DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTCOV_050 = 02]
What is the main reason why you did not receive the flu and COVID-19 vaccines at the same visit? Would you say it is because…?
INTERVIEWER INSTRUCTIONS:
If the respondents say, 'all of the above', or select several reasons, prompt them to pick, among those, the most important reason
(READ LIST. ONLY ONE MENTION)
Receiving both vaccines might cause a higher number of adverse reactions/side effects 01
Vaccines could be less effective than getting them at different time points 02
Two vaccines at the same time can overload my immune system 03
I only wanted or needed one of the two vaccines 04
I was not offered the option/not able to book an appointment to receive both at the same visit 05
Other reasons; specify 6
(DO NOT READ) Valid skip/ Not applicable 7
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
How would you rate your level of vaccine fatigue? That is the feeling of being tired of hearing about vaccination or of having to get vaccinated.
(READ LIST. ONLY ONE MENTION)
Very high fatigue 01
High fatigue 02
Moderate fatigue 03
Low fatigue 04
I am not fatigued at all 05
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
INTERVIEWER SCRIPT: The next few questions will ask you how much you agree or disagree with a series of statements. The options are: strongly disagree, somewhat disagree, somewhat agree or strongly agree.
[ASK ALL]
"It's better to get natural immunity (protection) from getting sick with the COVID-19 rather than getting vaccinated."
Responses:
Strongly disagree 01
Somewhat disagree 02
Somewhat agree 03
Strongly agree 04
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK ALL]
INTERVIEWER INSTRUCTIONS: (READ LIST - MULTIPLE ANSWERS ALLOWED)
Please select all that apply.
If you wanted to keep up to date on all things about vaccination, what or who would be the sources of information you would consult?
Your own family physician 01
Other health professional (e.g. nurse, pharmacist) 02
Alternative health practitioner (chiropractor, naturopath, osteopath, homeopath, etc.) 03
Health Canada, Public Health Agency of Canada 04
Provincial/territorial/regional Health Authority 05
World Health Organization (WHO) 06
Health scientists and researchers 07
Info-Santé or Telehealth telephone lines, 811 08
Your family, friends or colleagues 09
Other people's experiences or knowledge 10
Another source (please specify) 96
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
[ASK ALL]
Which of the following sources would you trust the most to provide you with adequate information about vaccination?
Your own family physician 01
Other health professional (e.g. nurse, pharmacist) 02
Alternative health practitioner (chiropractor, naturopath, osteopath, homeopath, etc.) 03
Health Canada, Public Health Agency of Canada 04
Provincial/territorial/regional Health Authority 05
World Health Organization (WHO) 06
Health scientists and researchers 07
Info-Santé or Telehealth telephone lines, 811 08
Your family, friends or colleagues 09
Other people's experiences or knowledge 10
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
INTERVIEWER SCRIPT:
The next questions are for statistical purposes only. It will allow us to group your answers with those of other similar respondents.
Scola
[ASK ALL]
[ORDRE DE LA LISTE : En ordre]
First, what is the highest level of formal education that you have completed?
INTERVIEWER INSTRUCTIONS: (DO NOT READ LIST. ONLY ONE ANSWER)
Grade 8 or less 01
Some high school 02
High School diploma or equivalent 03
Registered Apprenticeship or other trades certificate or diploma 04
College, CEGEP or other non-university certificate or diploma 05
University certificate or diploma below bachelor's level 06
Bachelor's degree 07
Post graduate degree above bachelor's level 08
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
Reven
[ASK ALL]
[LIST ORDER : IN ORDER]
Which of the following categories best describes your total household income for the year 2022? That is, the total income of all persons in your household combined, before taxes.
INTERVIEWER INSTRUCTIONS: (READ LIST UP TO CATEGORY THAT RESPONDENT SELECTS. ONE MENTION POSSIBLE.)
...Under $20,000 01
... $20,000 to $39,999 02
... $40,000 to $59,999 03
... $60,000 to $79,999 04
... $80,000 to $99,999 05
... $100,000 to $149,999 06
…$150,000 and above 07
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
[ASK ALL]
Were you born in Canada?
INTERVIEWER INSTRUCTIONS: (DO NOT READ LIST. ONLY ONE MENTION)
Yes 1
No 0
(DO NOT READ) Don't know 8
(DO NOT READ) Refusal 9
[ASK IF ADTDEM_060=0]
In which country were you born?
INTERVIEWER INSTRUCTIONS: (DO NOT READ LIST. ONLY ONE MENTION)
China 156
France 250
Germany 276
Greece 300
Guyana 328
Hong Kong 344
India 356
Iran 364
Italy 380
Jamaica 388
Lebanon 422
Netherlands 528
Pakistan 586
Philippines 608
Poland 616
Portugal 620
Romania 642
Korea, Republic of (South Korea) 410
Sri Lanka 144
Taiwan 158
Trinidad and Tobago 780
United Kingdom 826
United States 840
Vietnam 704
Algeria 012
Belgium 056
Colombia 170
Afghanistan 004
Bangladesh 050
Turkey 792
Ukraine 804
Other; specify 996
(DO NOT READ) Valid skip/ Not applicable 997
(DO NOT READ) Don't know 998
(DO NOT READ) Refusal 999
[ASK IF ADTDEM_060=0]
[NUMERIC: BORNES Min=1, Max=100]
How many years have you been living in Canada?
INTERVIEWER INSTRUCTIONS: (RECORD NUMBER OF YEARS.)
Record number of years: XXX
(DO NOT READ) Valid skip/ Not applicable 997
(DO NOT READ) Don't know 998
(DO NOT READ) Refusal 999
[ASK ALL]
Do you have any children aged 17 and under living in your household?
Yes 01
No 00
(DO NOT READ) Don't know 98
(DO NOT READ) Refusal 99
This concludes the questions we have for you. Your answers will help improve services that impact Canadians like you.
We greatly appreciate your cooperation and thank you for your participation.
Leger has been purchasing its samples from ASDE Survey Sampler, a reputable and reliable supplier, for over 15 years.